A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma
Sasan Roayaie(White Plains Hospital), Myron Schwartz(Icahn School of Medicine at Mount Sinai), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Spiros Hiotis(Icahn School of Medicine at Mount Sinai), Iris Blume(Icahn School of Medicine at Mount Sinai), Daniel M. Labow(Danbury Hospital), Swan N. Thung(Icahn School of Medicine at Mount Sinai), Maria Guido(University of Padua), M. Isabel Fiel(Icahn School of Medicine at Mount Sinai)
Cited by 670
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k